Literature DB >> 9533062

Antacid-induced hypermagnesemia in a patient with normal renal function and bowel obstruction.

S A McLaughlin1, P E McKinney.   

Abstract

OBJECTIVE: To report a case of severe hypermagnesemia caused by magnesium hydroxide in a woman with normal renal function. CASE
SUMMARY: A 42-year-old Hispanic woman with schizophrenia and bipolar affective disorder was transported from jail to the emergency department with confusion, abdominal pain, vomiting, and constipation. She had been treated in jail with magnesium hydroxide, ordered as milk of magnesia 30 mL po each night and Maalox 30 mL po three times daily. Additional medications included lithium carbonate 300 mg po three times daily, chlorpromazine 150 mg po three times daily, benztropine mesylate 1 mg po twice daily, and docusate sodium 100 mg po each morning. Her temperature was 35.1 degrees C, blood pressure 108/58 mm Hg, heart rate 112 beats/min, and respiratory rate 24 breaths/min. She would respond only briefly to voice or painful stimuli. Her abdomen was distended and diffusely tender. Laboratory tests included serum magnesium concentration 9.1 mEq/L (normal 1.3-2), blood urea nitrogen 16 mg/dL (8-22), creatinine 0.9 mg/dL (0.5-1.1), calcium 3.9 mEq/L (4.2-5.2), and lithium 1.0 mEq/L. A laparotomy was performed, and an adhesive band from a previous oophorectomy was found to be compressing the sigmoid colon. Hypermagnesemia, hypothermia, and hypotension continued in the intensive care unit. Despite successful treatment of the hypermagnesemia with calcium, intravenous fluids, and furosemide, the patient's cardiac rhythm degenerated into fatal, pulseless electrical activity on postoperative day 2. DISCUSSION: This case of severe hypermagnesemia from magnesium hydroxide ingestion illustrates many of the risk factors for hypermagnesemia in patients with normal renal function. People using magnesium-containing medications for relief of gastrointestinal distress may be at increased risk for hypermagnesemia. A brief review of magnesium physiology, clinical effects, and treatment is provided. Frequent use of the laboratory to identify hypermagnesemia is encouraged because it is often a clinically unexpected finding and responds well to early treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533062     DOI: 10.1345/aph.17284

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

1.  Fatal hypermagnesemia induced by preoperative colon preparation in an elderly woman: report of a case.

Authors:  Chieko Uchiyama; Takeshi Kato; Kodo Tomida; Rei Suzuki; Ken Nakata; Michiko Hamanaka; Takashi Kanemura; Masaaki Izumi; Shigeyuki Tamura
Journal:  Clin J Gastroenterol       Date:  2013-01-25

2.  Serum magnesium concentration in children with functional constipation treated with magnesium oxide.

Authors:  Maiko Tatsuki; Reiko Miyazawa; Takeshi Tomomasa; Takashi Ishige; Tomoko Nakazawa; Hirokazu Arakawa
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

3.  Circulatory collapse caused by unnoticed hypermagnesemia in a hospitalized patient.

Authors:  MinHye So; Hiroaki Ito; Kazuya Sobue; Takako Tsuda; Hirotada Katsuya
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

4.  Magnesium sulfate for acute asthma in adults: a systematic literature review.

Authors:  Woo-Jung Song; Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2012-01-31

5.  Magnesium basics.

Authors:  Wilhelm Jahnen-Dechent; Markus Ketteler
Journal:  Clin Kidney J       Date:  2012-02

6.  The characteristics of patients with hypermagnesemia who underwent emergency hemodialysis.

Authors:  Mana Nishikawa; Noriaki Shimada; Motoko Kanzaki; Tetsunori Ikegami; Toshio Fukuoka; Masaki Fukushima; Kenichiro Asano
Journal:  Acute Med Surg       Date:  2018-02-21

Review 7.  Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review.

Authors:  D T Dibaba; P Xun; K He
Journal:  Eur J Clin Nutr       Date:  2014-02-12       Impact factor: 4.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.